Leucid Bio

London
24 Total Employees
Leucid is progressing novel CAR T therapies that produce a better and more durable response than previous CAR T generations, improving treatment outcomes and saving the lives of patients with refractory cancers.

Leucid Bio Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
London, England